As of April 16, 2025, Mereo BioPharma Group (MREO) has a market cap of $0.32 billion USD. According to our data, Mereo BioPharma Group is ranked No.6453 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.32 B |
-41.44%
|
Dec 31, 2024 | $0.54 B |
51.52%
|
Dec 29, 2023 | $0.36 B |
208.00%
|
Dec 30, 2022 | $0.12 B |
-53.13%
|
Dec 31, 2021 | $0.25 B |
-55.31%
|
Dec 31, 2020 | $0.56 B |
9.15%
|
Dec 31, 2019 | $0.51 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Adaptimmune Therapeutics
ADAP
|
$64.18 M |
-0.000 M
|
![]() UK
|
![]() Blueprint Medicines
BPMC
|
$5.21 B |
0.000 M
|
![]() USA
|
![]() Deciphera Pharmaceuticals
DCPH
|
$2.21 B |
2.213 B
|
![]() USA
|
![]() Karyopharm Therapeutics
KPTI
|
$35.85 M |
-0.000 M
|
![]() USA
|
![]() MacroGenics
MGNX
|
$79.49 M |
-0.000 M
|
![]() USA
|
![]() Nektar Therapeutics
NKTR
|
$0.12 B |
0.000 M
|
![]() USA
|
![]() Protagonist Therapeutics
PTGX
|
$2.88 B |
0.000 M
|
![]() USA
|
![]() Syndax Pharmaceuticals
SNDX
|
$0.97 B |
0.000 M
|
![]() USA
|
![]() TG Therapeutics
TGTX
|
$6.13 B |
-0.000 M
|
![]() USA
|
![]() Zymeworks
ZYME
|
$0.76 B |
-0.000 M
|
![]() Canada
|
Market Cap | = | MREO Stock Price | * | MREO Shares Outstanding |
= | $2.00 | * | 0.16 B | |
= | $0.32 B |